Corcept Therapeutics, Inc. (NASDAQ: CORT)
March 22nd, 2011 we released our public article, "TooNiceStocks Initiates Coverage on Corcept Therapeutics Inc. (NASDAQ: CORT) Evaluating the Benefits of Corlux". Future implications show that CORT will request priority review with the U.S. Food and Drug Administration. TooNiceStocks members were notified @ $3.93 and rallied up to $5.07, thats a 29% increase. Read full report here.


